Gene · 2549
Papers2,374
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 2,374
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Anti-VEGF Drugs in the Treatment of Multiple Myeloma Patients. | J Clin Med | 2020 | 32517267 | PubTator, text mining | PubMed |
| Circular RNA circSATB2 promotes progression of non-small cell lung cancer cells. | Mol Cancer | 2020 | 32493389 | PubTator, text mining | PubMed |
| The regulation and function of CD20: an "enigma" of B-cell biology and targeted therapy. | Haematologica | 2020 | 32482755 | PubTator, text mining | PubMed |
| Cardiotoxicity of the BCR-ABL1 tyrosine kinase inhibitors: Emphasis on ponatinib. | Int J Cardiol | 2020 | 32470534 | PubTator, text mining | PubMed |
| Targeting the HGF/MET Axis in Cancer Therapy: Challenges in Resistance and Opportunities for Improvement. | Front Cell Dev Biol | 2020 | 32435640 | PubTator, text mining | PubMed |
| Dysregulation of Signaling Pathways Due to Differentially Expressed Genes From the B-Cell Transcriptomes of Systemic Lupus Erythematosus Patients - A Bioinformatics Approach. | Front Bioeng Biotechnol | 2020 | 32426333 | PubTator, text mining | PubMed |
| Functional Link between miR-200a and ELK3 Regulates the Metastatic Nature of Breast Cancer. | Cancers (Basel) | 2020 | 32414208 | PubTator, text mining | PubMed |
| Differential responses to kinase inhibition in FGFR2-addicted triple negative breast cancer cells: a quantitative phosphoproteomics study. | Sci Rep | 2020 | 32409632 | PubTator, text mining | PubMed |
| Structural Determinants of Phosphopeptide Binding to the N-Terminal Src Homology 2 Domain of the SHP2 Phosphatase. | J Chem Inf Model | 2020 | 32395997 | PubTator, text mining | PubMed |
| The Emerging Role of the FGF/FGFR Pathway in Gastrointestinal Stromal Tumor. | Int J Mol Sci | 2020 | 32392832 | PubTator, text mining | PubMed |
| LncRNA TUG1 promotes the progression of colorectal cancer via the miR-138-5p/ZEB2 axis. | Biosci Rep | 2020 | 32391554 | PubTator, text mining | PubMed |
| Targeting AKT/mTOR in Oral Cancer: Mechanisms and Advances in Clinical Trials. | Int J Mol Sci | 2020 | 32384682 | PubTator, text mining | PubMed |
| RNF220 is required for cerebellum development and regulates medulloblastoma progression through epigenetic modulation of Shh signaling. | Development | 2020 | 32376680 | PubTator, text mining | PubMed |
| Genetic contributions to the etiology of anorexia nervosa: New perspectives in molecular diagnosis and treatment. | Mol Genet Genomic Med | 2020 | 32368866 | PubTator, text mining | PubMed |
| miR-196B-5P and miR-200B-3P Are Differentially Expressed in Medulloblastomas of Adults and Children. | Diagnostics (Basel) | 2020 | 32365560 | PubTator, text mining | PubMed |
| A novel targeted RNA-Seq panel identifies a subset of adult patients with acute lymphoblastic leukemia with BCR-ABL1-like characteristics. | Blood Cancer J | 2020 | 32332702 | PubTator, text mining | PubMed |
| Airway Epithelial Dynamics in Allergy and Related Chronic Inflammatory Airway Diseases. | Front Cell Dev Biol | 2020 | 32292784 | PubTator, text mining | PubMed |
| Progestins Related to Progesterone and Testosterone Elicit Divergent Human Endometrial Transcriptomes and Biofunctions. | Int J Mol Sci | 2020 | 32283828 | PubTator, text mining | PubMed |
| Bidirectional interaction of lncRNA AFAP1-AS1 and CRKL accelerates the proliferative and metastatic abilities of hepatocarcinoma cells. | J Adv Res | 2020 | 32280542 | PubTator, text mining | PubMed |
| Role of neoadjuvant chemotherapy in metastatic medulloblastoma: a comparative study in 92 children. | Neuro Oncol | 2020 | 32267940 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2549/papers?page=43